respons
injuri
infect
bodi
mobil
cell
immun
system
initi
inflammatori
respons
site
damag
critic
step
respons
adhes
circul
leukocyt
endotheli
cell
line
blood
vessel
allow
subsequ
migrat
across
endotheli
cell
barrier
access
insult
damag
infect
tissu
rich
vasoact
peptid
chemoattract
product
stimul
endotheli
cell
leukocyt
induc
activ
cell
surfac
molecul
mediat
adhes
transmigr
process
ectoenzym
emerg
recent
group
surfac
molecul
particip
leukocyt
activ
traffick
review
ref
although
proteolysi
vasoact
peptid
chemokin
ectoenzym
mediat
leukocyt
migrat
case
frequent
function
independ
enzymat
activ
trigger
signal
cascad
lead
calcium
flux
cytoskelet
rearrang
releas
inflammatori
mediat
integrin
activ
function
physic
associ
adhes
molecul
regul
signal
shed
n
ectoenzym
predominantli
express
monocyt
cell
epitheli
cell
liver
intestin
kidney
recent
shown
potent
activ
endotheli
cell
angiogen
vasculatur
addit
enzymat
regul
neuroregulatori
vasoact
peptid
receptor
promin
subgroup
coronavirus
includ
human
coronaviru
structur
consist
larg
extracellular
domain
contain
enzymat
activ
site
transmembran
domain
short
cytoplasm
tail
known
signal
motif
thu
believ
intrins
incap
signal
may
function
signal
regul
molecul
recent
other
report
antibodi
result
monocyt
cell
activ
via
signal
mechan
activ
character
increas
phagocytosi
ca
flux
cytokin
secret
increas
adhes
capac
cell
adhes
demonstr
depend
protein
independ
enzymat
activ
regul
monocyt
cell
adhes
express
monocyt
endotheli
cell
present
work
ask
activ
monocyt
monocyt
cell
affect
capac
adher
transmigr
rest
activ
endothelium
vitro
vivo
result
indic
monocyt
cell
activ
antibodi
natur
ligand
result
dramat
signal
increas
adhes
endothelium
distinct
induc
inflammatori
cytokin
adhes
requir
cluster
involv
complex
contain
monocyt
endotheli
suggest
direct
particip
process
importantli
block
interact
specif
antibodi
solubl
abrog
effect
final
block
interact
vivo
specif
antibodi
result
reduct
periton
leukocyt
infiltr
murin
model
periton
support
fundament
role
leukocyt
transendotheli
migrat
inflammatori
site
primari
huvec
cambrex
bioscienc
hopkinton
usa
maintain
accord
provid
instruct
cell
murin
myeloid
cell
line
cell
hemangioendothelioma
eoma
cell
american
type
cell
cultur
collect
atcc
manassa
va
usa
pbmc
allcel
emeryvil
ca
usa
mab
f
ab
fab
fragment
purifi
hybridoma
donat
dr
meenhard
herlyn
wistar
institut
philadelphia
pa
usa
mab
sigma
chemic
co
st
loui
mo
usa
bd
pharmingen
san
diego
ca
usa
respect
mab
describ
previous
hamster
mab
purifi
hybridoma
provid
dr
william
paul
nation
institut
health
nih
bethesda
md
usa
hamster
igg
biolegend
san
diego
ca
usa
mab
gift
dr
william
muller
cornel
univers
ithaca
ny
usa
mab
ancel
corp
bayport
mn
usa
mab
alexi
biochem
switzerland
mab
pierc
biotechnolog
rockford
il
usa
mous
control
goat
gam
f
ab
fragment
sigma
chemic
co
gam
f
ab
fragment
beckman
coulter
fullerton
ca
usa
amplifi
human
cdna
purifi
subclon
xhoisacii
site
vector
bd
clontech
mountain
view
ca
usa
pcr
clone
eoma
cell
stabli
transfect
use
lipofectamin
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
select
carri
use
geneticin
gibco
grand
island
ny
usa
concentr
cell
sort
use
facsvantag
flow
cytomet
bd
pharmingen
huvec
seed
plate
grown
confluenc
h
medium
cambrex
east
rutherford
nj
usa
subsequ
untreat
monocyt
cell
ad
monolay
adhes
allow
proceed
min
indic
condit
assay
triplic
unbound
monocyt
cell
wash
away
remain
cell
lyse
detail
descript
see
supplement
method
fluoresc
quantifi
cytofluor
persept
biosystem
framingham
usa
data
repres
fluoresc
obtain
sampl
normal
fluoresc
correspond
cell
adher
onto
untreat
control
protocol
use
adhes
assay
transfect
cell
block
experi
recombin
monolay
monocyt
cell
wash
three
time
subsequ
incub
indic
concentr
min
unbound
protein
wash
away
adhes
allow
proceed
presenc
protein
concentr
vehicl
pb
equival
volum
indic
obtain
atcc
propag
human
lung
cell
line
also
obtain
atcc
viru
titer
plaqu
assay
cell
viru
supernat
purifi
ultracentrifug
describ
previous
murin
coronaviru
murin
hepat
viru
briefli
virion
interfac
sucros
sucros
tri
maleat
salin
buffer
tm
ph
harvest
purifi
equilibrium
ultracentrifug
sucros
densiti
gradient
tm
viru
band
dialyz
remov
sucros
suspend
dmem
high
glucos
fb
penicillin
streptomycin
fungizon
gibco
viru
residu
infect
determin
plaqu
assay
titer
viru
irradi
pfuml
pfuml
respect
aliquot
viru
store
adhes
experi
carri
use
concentr
viru
correspond
multipl
inocul
indic
prior
uv
irradi
well
plate
pierc
biotechnolog
coat
indic
concentr
pb
overnight
three
wash
block
bsa
h
room
temperatur
cell
pretreat
mab
min
wash
three
time
ad
plate
min
plate
wash
seven
time
pb
adhes
quantifi
fluorometri
describ
cell
nontransfect
stabli
express
empti
vector
truncat
form
grown
confluenc
mm
cultur
dish
cell
preincub
biotinyl
mab
min
sever
wash
cell
allow
adher
min
monolay
adher
monocyt
cell
scrape
presenc
lysi
buffer
tri
mm
nacl
mm
glycerol
triton
contain
proteas
inhibitor
roch
nutley
nj
usa
nonadher
cell
collect
separ
pellet
lyse
mix
adher
lysat
obtain
amount
protein
monocyt
cell
sampl
monocyt
cell
precipit
bead
invitrogen
h
immunoprecipit
protein
separ
transfer
onto
polyvinyliden
difluorid
membran
millipor
bedford
usa
cell
detect
mab
dilut
invitrogen
follow
antibodi
amersham
bioscienc
piscataway
nj
usa
chemiluminesc
signal
detect
use
chemiluminesc
hrp
substrat
millipor
strip
glycin
ph
block
membran
blot
use
streptavidin
pierc
biotechnolog
fvb
femal
mice
charl
river
laboratori
portag
mi
usa
anesthet
ip
inject
avertin
prepar
use
g
ml
ml
distil
water
periton
induc
ip
inject
thioglycol
ml
subsequ
dose
hamster
mab
clone
steril
salin
inject
iv
space
control
volum
salin
hamster
igg
adjust
equival
volum
inject
control
anim
periton
cell
collect
h
later
count
use
neubauer
hemocytomet
subsequ
cell
fix
slide
paraformaldehyd
stain
h
e
differenti
determin
number
mononuclear
versu
polymorphonuclear
cell
signific
increas
number
recruit
macrophag
report
immedi
euthanasia
sampl
peripher
blood
collect
cardiac
punctur
erythrocyt
lyse
hypoton
shock
remain
leukocyt
fix
stain
antibodi
analyz
flow
cytometri
paraffin
section
periton
tissu
stain
h
e
photograph
use
zeiss
axiovert
microscop
object
anim
procedur
approv
univers
connecticut
health
center
anim
care
committe
farmington
ct
usa
previou
studi
observ
pretreat
monocyt
monocyt
cell
mab
induc
rapid
adhes
signal
enzymat
manner
express
monocyt
endotheli
cell
tumor
vessel
vessel
ischem
heart
shown
inflammatori
cytokin
ask
ligat
would
influenc
monocyteendotheli
interact
critic
monocyt
traffick
inflamm
pretreat
primari
huvec
express
high
level
respons
growth
factor
cultur
medium
mab
prior
addit
label
monocyt
cell
significantli
induc
monocyt
cell
adhes
fig
importantli
adhes
induc
cell
pretreat
mab
data
shown
suggest
induct
adhes
activ
process
result
associ
via
unbound
fab
portion
mab
bind
molecul
opposit
cell
strengthen
conclus
produc
stabl
cell
line
express
human
epitheli
cell
line
assay
monocyt
cell
adhes
although
high
express
transfect
effect
basal
adhes
monocyt
cell
see
fig
pretreat
mab
antibodi
capabl
induc
similar
increas
adhes
wide
rang
dose
although
maxim
induct
observ
low
antibodi
concentr
fig
epitop
express
cell
monolay
result
clearli
demonstr
adhes
result
singl
antibodi
simultan
bind
cell
popul
like
influenc
intrins
adhes
properti
cell
expand
investig
use
three
addit
mab
vari
epitop
specif
pretreat
huvec
summar
tabl
maxim
induct
monocyt
cell
adhes
observ
two
independ
mab
fig
recogn
common
epitop
supplement
fig
shown
import
infect
contrast
pretreat
huvec
mab
recogn
distinct
epitop
inhibit
enzymat
activ
show
modest
yet
signific
induct
monocyt
cell
adhes
third
reagent
mab
inhibit
viral
infect
block
enzymat
activ
expect
effect
monocyt
cell
adhes
huvec
treatment
cell
bestatin
chemic
inhibitor
enzymat
activ
interestingli
pretreat
adher
monocyt
cell
mab
prior
addit
untreat
endotheli
monolay
produc
ident
pattern
adhes
fig
even
higher
effect
pretreat
huvec
averag
higher
adhes
treat
vs
treat
huvec
thu
would
appear
share
critic
region
molecul
particip
variou
function
ligat
affect
adhes
properti
monocyt
cell
endotheli
cell
importantli
primari
pbmc
use
place
cell
line
observ
similar
dramat
increas
adhes
huvec
pbmc
huvec
pretreat
mab
fig
similarli
primari
macrophag
lung
microvascular
endotheli
cell
behav
analog
see
supplement
fig
monocyt
small
percentag
granulocyt
popul
pbmc
result
clearli
demonstr
ligat
endotheli
myeloid
cell
specif
antibodi
induc
adhes
primari
myeloid
cell
monocyt
cell
line
thu
cell
line
valid
model
primari
monocyteendotheli
interact
previous
report
determin
kinet
adhes
endotheli
monolay
supplement
fig
although
pretreat
antibodi
variou
time
period
rapidli
induc
signific
adhes
adhes
appear
transient
number
monocyt
cell
attach
monolay
decreas
progress
perhap
suggest
subsequ
initi
adhes
cell
becom
refractori
longer
abl
adher
mani
bodi
mimic
ligand
bind
receptor
target
thu
trigger
subsequ
signal
transduct
experi
determin
differ
abil
antibodi
induc
adhes
result
abil
molecul
cell
surfac
found
f
ab
fragment
mab
fab
fragment
capabl
induc
monocyt
cell
adhes
preincub
cell
fig
bind
capac
two
reagent
compar
fig
inset
similarli
nonactiv
mab
f
ab
fragment
secondari
antibodi
result
high
level
adhes
similar
obtain
equival
fragment
mab
ident
result
obtain
huvec
shown
addit
antibodi
fragment
capabl
induc
adhes
effect
mediat
fcr
opposit
cell
cluster
activ
inact
antibodi
visual
confoc
imag
cell
treat
fluoresc
label
antibodi
mab
noninduc
cluster
molecul
cell
surfac
fig
similar
aggreg
observ
huvec
supplement
fig
b
cell
shown
mous
endotheli
cell
line
eoma
fig
express
treat
mab
compar
untreat
cell
thu
report
homotyp
aggreg
ha
cluster
requir
alter
adhes
properti
cell
bind
receptor
result
subsequ
infect
interestingli
shown
maxim
induct
adhes
obtain
antibodi
effici
block
bind
fig
suggest
ligand
bind
particular
epitop
may
common
initi
cell
adhes
viru
entri
activ
delin
scope
induct
adhes
determin
natur
ligand
also
induc
monocyt
cellendotheli
cell
adhes
test
effect
treatment
monocyt
cell
monocyt
cell
treat
inactiv
viru
contain
trimer
spikesvirion
show
increas
adhes
fig
doserespons
curv
suggest
process
taken
togeth
result
demonstr
cluster
specif
mab
natur
multival
ligand
increas
cell
adhes
process
may
exploit
viru
manipul
immun
cell
behavior
monocyt
aggreg
activ
redistribut
zone
contact
treatment
excess
antibodi
abrog
adhes
rais
possibl
may
activ
particip
adhes
investig
local
endotheli
target
cell
would
also
support
role
adhes
molecul
assess
distribut
eoma
cell
fig
huvec
monolay
stain
immunofluoresc
label
mab
supplement
fig
isol
cell
type
studi
rel
evenli
distribut
cell
membran
fig
supplement
video
appear
concentr
point
contact
cell
encount
previous
report
cell
type
ref
fig
center
similarli
imag
monocyt
cell
adher
untreat
cell
express
show
strongli
express
filopodi
structur
protrud
monolay
toward
adher
monocyt
cell
fig
right
supplement
video
analog
structur
term
project
endotheli
dock
structur
observ
leukocyt
adhes
transmigr
support
role
process
strengthen
notion
concurr
treatment
monocyt
cell
endotheli
cell
popul
mab
altern
adhes
continu
presenc
mab
result
extrem
modest
increas
adhes
compar
treatment
individu
cell
popul
fig
data
shown
suggest
blockad
homophil
interact
monocyt
endotheli
molecul
might
particip
directli
adhes
process
case
must
express
cell
type
adhes
occur
inde
shown
figur
use
cell
describ
found
monocyt
cell
bind
exclus
monolay
nontransfect
control
demonstr
express
requir
mediat
adhes
addit
monocyt
cell
bind
monolay
presum
block
homophil
interact
therefor
accumul
endotheli
dock
structur
requir
monolay
bind
monocyt
cell
although
previou
experi
impli
interact
directli
address
monocyt
associ
express
monolay
investig
question
cell
activ
biotinyl
form
mab
wash
allow
adher
monolay
monocyt
immunoprecipit
total
lysat
cocultur
use
streptavidin
bead
result
complex
probe
presenc
epitop
fig
protein
correspond
molecular
weight
matur
readili
appar
lysat
condit
contain
monolay
express
nontransfect
control
monolay
cell
express
lack
extracellular
domain
verifi
specif
precipit
band
importantli
nonspecif
interact
epitop
rule
lack
complex
immunoprecipit
monocyt
cell
shown
similarli
excess
antibodi
respons
coimmunoprecipit
protein
precipit
individu
popul
first
lyse
mix
prior
immunoprecipit
thu
prevent
endothelialmonocyt
cell
interact
data
shown
addit
observ
abrog
adhes
monocyt
cell
huvec
monocyt
cell
treat
truncat
recombin
even
protein
longer
present
adhes
assay
basal
adhes
unaffect
support
direct
interact
fig
howev
reciproc
experi
treatment
huvec
show
signific
clearli
less
effici
inhibit
adhes
fig
unless
protein
allow
remain
assay
signifi
preferenti
bind
monocyt
cell
compar
huvec
suggest
complex
interact
may
involv
exposur
auxiliari
molecul
ligand
monocyt
cell
cluster
solubl
form
protein
capabl
regul
interact
altern
differenti
glycosyl
molecul
may
play
role
propos
least
five
differ
glycoform
exist
final
rest
monocyt
cell
specif
adher
immobil
purifi
manner
fig
confirm
function
adhes
molecul
mediat
interact
monocyt
cell
target
cell
appear
express
target
cell
suffici
bind
monocyt
cell
possibl
homophil
interact
result
passiv
associ
extracellular
target
monolay
ligand
monocyt
cell
cluster
howev
adhes
requir
signal
transduct
cascad
monocyt
cell
endotheli
cell
preincub
either
cell
type
tyrosin
kinas
inhibitor
herbimycin
prior
antibodi
treatment
profoundli
inhibit
adhes
effect
basal
adhes
concentr
use
fig
contrast
g
receptor
signal
involv
pretreat
monocyt
cell
pertussi
toxin
prior
antibodi
activ
affect
adhes
data
shown
result
suggest
adhes
induc
ligat
requir
signal
cascad
cell
type
block
mechan
one
cell
popul
influenc
induct
adhes
ligat
opposit
cell
interestingli
signal
cascad
trigger
monocyt
cell
consist
appear
predomin
induc
huvec
adhes
alway
potent
affect
monocyt
signal
transduct
mechan
inhibit
regardless
cell
type
treat
mab
fig
import
consequ
tyrosin
kinas
signal
transduct
actin
polymer
absolut
requir
monocyt
adhes
target
cell
shown
monocyt
adhes
clearli
concentr
lead
edg
monocyt
cell
migrat
toward
cellular
aggreg
activ
redistribut
zone
contact
aggreg
cell
similarli
redistribut
phagocyt
cup
phagocytosi
enrich
lead
edg
membran
project
endotheli
cell
fig
demonstr
frequent
accumul
site
actin
process
determin
whether
microfila
assembl
play
role
adhes
inhibit
process
assess
adhes
follow
mab
treatment
endotheli
cell
fig
monocyt
cell
fig
endotheli
cell
ligat
adhes
essenti
unaffect
block
endotheli
actin
polymer
fig
lane
analog
previou
report
studi
microvillar
structur
leukocyt
traffick
similar
fig
endotheli
cell
contrast
pretreat
persist
treatment
monocyt
cell
complet
abrog
adhes
endotheli
cell
regardless
statu
endotheli
cell
actin
polymer
fig
lane
impli
downstream
consequ
ligat
monocyt
greater
impact
adhes
endotheli
cell
similarli
reciproc
experi
fig
monocyt
cell
preincub
show
nearli
decreas
adhes
fig
lane
complet
abrog
inhibitor
present
entir
assay
shown
cell
pretreat
fig
lane
addit
cytochalasin
treatment
huvec
affect
adhes
monocyt
cell
fig
lane
clearli
demonstr
microfila
assembl
princip
consequ
signal
transduct
monocyt
cell
accordingli
visual
actin
dynam
monocyt
cell
fluoresc
label
phalloidin
show
induc
strike
format
numer
protrus
antibodi
activ
compar
untreat
cell
fig
time
period
consist
kinet
adhes
similar
observ
treatment
monocyt
cell
activ
antibodi
induc
ca
flux
supplement
fig
ref
contrast
huvec
show
discern
differ
actin
local
data
shown
agreement
cytochalasin
inhibit
data
argu
endotheli
cell
induc
downstream
consequ
qualit
distinct
seen
monocyt
cell
increas
adhes
circul
leukocyt
endotheli
cell
would
predict
enhanc
abil
cell
migrat
across
endotheli
cell
monolay
site
inflamm
determin
effect
ligat
inflammatori
transendotheli
migrat
vivo
induc
periton
mice
treat
iv
either
vehicl
control
igg
antibodi
determin
induc
monocyt
cell
adhes
supplement
fig
assess
leukocyt
infiltr
periton
caviti
surprisingli
although
cohort
control
anim
show
intens
leukocyt
infiltr
periton
wall
correl
number
periton
leukocyt
number
clearli
reduc
anim
fig
interestingli
earli
h
rel
represent
infiltr
granulocyt
versu
mononuclear
cell
periton
fluid
appear
affect
mab
treatment
determin
direct
quantif
rel
number
harvest
periton
cell
fig
addit
direct
assess
peripher
blood
cell
popul
fac
analysi
monocyt
neutrophil
fig
show
equival
number
anim
compar
control
argu
cell
death
mechan
reduc
periton
infiltr
therefor
result
indic
ligat
significantli
affect
leukocyt
traffick
vivo
suggest
contribut
inflammatori
process
complex
mechan
previous
report
treatment
human
monocyt
cell
mab
potent
induc
ha
signal
manner
demonstr
ligat
primari
human
myeloid
cell
monocyt
cell
line
also
promot
adhes
endotheli
cell
vitro
static
condit
importantli
find
recapitul
preliminari
studi
physiolog
flow
data
shown
show
induct
adhes
strictli
depend
abil
antibodi
cluster
requir
activ
tyrosin
kinas
express
monocyt
cell
endotheli
cell
accordingli
multival
specif
bind
cluster
also
induc
monocyt
cell
adhes
endotheli
cell
thu
treatment
monocyt
cell
cluster
antibodi
function
duplic
respons
via
natur
ligand
underscor
potenti
vivo
relev
process
demonstr
use
antibodi
reagent
studi
receptor
function
studi
demonstr
immunocomplex
interact
cell
contain
monocyt
endotheli
like
adhes
molecul
purifi
recombin
abl
support
monocyt
cell
adhes
suggest
function
adhes
molecul
directli
mediat
interact
howev
observ
effici
block
adhes
monocyt
cell
modest
effect
huvec
suggest
differenti
bind
result
altern
glycosyl
form
indirect
heterophil
interact
possibl
via
adaptorbridg
molecul
monocyt
cell
activ
enabl
bind
monolay
protein
shown
regul
monocyt
adhes
transendotheli
migrat
also
ligand
particip
monocyt
cell
adhes
preliminari
studi
monocyt
cellendotheli
interact
partial
block
antibodi
consist
contributori
role
adhes
data
shown
thu
possibl
adhes
molecul
establish
homophil
heterophil
interact
would
explain
incomplet
block
antibodi
homophil
interact
could
result
cluster
induc
increas
avid
propos
integrin
cadherin
cellular
adhes
molecul
thu
may
also
particip
adhes
endotheli
cell
altern
cluster
could
result
conform
chang
expos
cryptic
epitop
report
antibodi
specif
activ
mab
mediat
adhes
regard
basal
condit
may
exist
inact
conform
cluster
convert
activ
oligomer
conform
capabl
interact
inact
molecul
untreat
cell
ligat
popul
would
produc
activ
form
incap
establish
product
interact
may
explain
impair
inflammatori
cell
infiltr
vivo
presenc
antibodi
see
fact
block
cluster
suggest
inact
conform
perhap
result
altern
glycosyl
also
explain
inabl
induc
adhes
addit
architectur
interact
downstream
consequ
ligat
import
issu
monocyt
cell
princip
result
cluster
appear
signal
event
involv
tyrosin
phosphoryl
ca
flux
supplement
fig
shown
mab
extend
observ
show
process
result
requisit
actin
polymer
demonstr
complet
abrog
adhes
subsequ
actin
polymer
lead
format
filopodi
structur
seen
membran
receptor
activ
stimuli
filopodi
structur
express
high
level
adhes
molecul
membran
enzym
tip
underscor
potenti
relev
filopodia
format
monocyt
adhes
pertin
studi
virus
use
filopodia
increas
effici
infect
possibl
receptor
interact
increas
monocyt
cell
adhes
may
induc
filopodia
format
therebi
modul
physiolog
process
advantag
explor
consequ
activ
infect
monocyt
adhes
underway
strike
reduct
immun
cell
accumul
treatment
antibodi
vivo
model
periton
suggest
contributori
role
physiolog
inflammatori
process
although
precis
mechan
remain
determin
although
initi
expect
increas
migrat
result
increas
adhes
addit
observ
would
also
consist
decreas
transmigr
presenc
mab
exclud
cell
death
result
mechan
straightforward
explan
continu
presenc
circul
mab
block
adhes
presum
result
block
bind
site
hyperactiv
endotheli
monocyt
preclud
bind
similar
vitro
observ
altern
although
effect
monocyt
cell
adhes
appar
within
min
addit
endotheli
monolay
vitro
kinet
studi
indic
adhes
diminish
less
origin
valu
h
cocultur
suggest
cell
bind
transient
detach
consist
observ
homotyp
leukocyt
adhes
possibl
signal
induc
ligat
biphas
first
induc
adhes
via
interact
later
time
antiadhes
perhap
render
cell
refractori
subsequ
adhes
via
classic
pathway
anoth
potenti
explan
induct
ha
occur
vivo
could
prevent
monocyteendotheli
interact
transmigr
howev
see
evid
cellular
aggreg
examin
tissu
treat
versu
untreat
anim
cell
aggreg
adhes
assay
time
final
exclud
interact
antibodi
circul
may
possibl
affect
transmigr
undetermin
mechan
experi
distinguish
among
possibl
current
way
final
block
infiltr
multipl
cell
type
model
impli
may
regul
migrat
immun
cell
neutrophil
activ
cell
also
express
signific
amount
contribut
enzymat
activ
german
function
capac
find
activ
antibodi
block
enzymat
activ
suggest
function
manner
addit
show
treatment
inhibitor
bestatin
effect
adhes
induc
adhes
altern
similar
mab
bind
cleavag
peptid
substrat
induc
conform
chang
expos
cryptic
epitop
suggest
enzymat
cleavag
substrat
may
prime
expos
epitop
necessari
cluster
inde
preliminari
studi
treatment
peptid
substrat
significantli
potenti
adhes
shown
consist
increas
epitop
enhanc
cluster
subsequ
signal
studi
necessari
determin
role
enzymat
activ
mechan
activ
intercellular
adhes
final
issu
put
obvious
critic
relev
current
studi
although
prematur
specul
natur
strong
support
exist
endogen
ligand
come
numer
exampl
virus
cellular
adhes
molecul
receptor
upon
infect
receptor
alter
adhes
properti
infect
cell
therebi
exploit
physiolog
function
gain
access
extravascular
tissu
furthermor
present
studi
relev
diseas
inflammatori
bowel
diseas
associ
cytomegaloviru
infect
produc
circul
autoantibodi
epitop
specif
activ
clone
could
potenti
play
role
inflammatori
process
addit
high
concentr
circul
describ
inflammatori
diseas
rais
possibl
act
endogen
modul
adhes
therefor
identif
adhes
molecul
mediat
monocyteendotheli
interact
open
novel
area
research
role
inflammatori
process
diseas
